Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain

Näytä muut versiot (1)

Objective: Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system associated with pathogenic autoantibodies against the astrocyte water channel protein aquaporin-4 (AQP4). The presence of neutrophils is a characteristic feature in NMO lesions in humans. Neu...

Bibliografiset tiedot
Päätekijät:	Saadoun, S, Waters, P, MacDonald, C, Bell, B, Vincent, A, Verkman, A, Papadopoulos, M
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2012

Samankaltaisia teoksia

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.
Tekijä: Saadoun, S, et al.
Julkaistu: (2012)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
Tekijä: Saadoun, S, et al.
Julkaistu: (2010)

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain
Tekijä: Papadopoulos, M, et al.
Julkaistu: (2011)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
Tekijä: Saadoun, S, et al.
Julkaistu: (2013)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
Tekijä: Saadoun, S, et al.
Julkaistu: (2013)

Neuromyelitis optica IgG causes placental inflammation and fetal death in mice
Tekijä: Saadoun, S, et al.
Julkaistu: (2013)

Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G
Tekijä: Christian M. Felix, et al.
Julkaistu: (2016-10-01)

Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
Tekijä: Xiaoming Yao, et al.
Julkaistu: (2017-07-01)

The effect of intravenous immunoglobulin on neuromyelitis optica
Tekijä: M.J. Magraner, et al.
Julkaistu: (2013-03-01)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
Tekijä: Kim, S-M, et al.
Julkaistu: (2016)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
Tekijä: Kim, S-M, et al.
Julkaistu: (2017)

Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
Tekijä: Tianjiao Duan, et al.
Julkaistu: (2018-10-01)

Tanshinone IIA alleviates brain damage in a mouse model of neuromyelitis optica spectrum disorder by inducing neutrophil apoptosis
Tekijä: Ye Gong, et al.
Julkaistu: (2020-06-01)

Complement activation in patients with neuromyelitis optica
Tekijä: Nytrova, P, et al.
Julkaistu: (2014)

Complement activation in patients with neuromyelitis optica.
Tekijä: Nytrova, P, et al.
Julkaistu: (2014)

Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema.
Tekijä: Julien Ratelade, et al.
Julkaistu: (2011-01-01)

Neuromyelitis Optica
Tekijä: Goyal V, et al.
Julkaistu: (2009-10-01)

Neuromyelitis optica
Tekijä: Jacob Anu, et al.
Julkaistu: (2007-01-01)

NMO-IgG in the diagnosis of neuromyelitis optica.
Tekijä: Jarius, S, et al.
Julkaistu: (2007)

The CSF Levels of Neutrophil‐Related Chemokines in Patients with Neuromyelitis Optica
Tekijä: Zhuhe Liu, et al.
Julkaistu: (2020-07-01)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
Tekijä: Waters, P, et al.
Julkaistu: (2008)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
Tekijä: Viegas, S, et al.
Julkaistu: (2009)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
Tekijä: Jacob, A, et al.
Julkaistu: (2012)

Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
Tekijä: Lukmanee Tradtrantip, et al.
Julkaistu: (2021-11-01)

CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
Tekijä: Lukmanee Tradtrantip, et al.
Julkaistu: (2019-03-01)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Tekijä: Min, J, et al.
Julkaistu: (2013)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
Tekijä: Jarius, S, et al.
Julkaistu: (2008)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
Tekijä: Waters, P, et al.
Julkaistu: (2015)

T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement.
Tekijä: Saadoun, S, et al.
Julkaistu: (2011)

Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
Tekijä: Tianjiao Duan, et al.
Julkaistu: (2019-07-01)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
Tekijä: Jarius, S, et al.
Julkaistu: (2008)

The evolving clinical spectrum of neuromyelitis optica
Tekijä: Viegas, S, et al.
Julkaistu: (2008)

The borderland of neuromyelitis optica.
Tekijä: Matthews, L, et al.
Julkaistu: (2009)

Pregnancy and neuromyelitis optica
Tekijä: Qiu-ying MA, et al.
Julkaistu: (2016-10-01)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Tekijä: Collongues, N, et al.
Julkaistu: (2013)

Potential therapeutic benefit of C1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model.
Tekijä: Lukmanee Tradtrantip, et al.
Julkaistu: (2014-01-01)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
Tekijä: Jarius, S, et al.
Julkaistu: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
Tekijä: Jarius, S, et al.
Julkaistu: (2008)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
Tekijä: Narayanan Unni, et al.
Julkaistu: (2013-01-01)

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
Tekijä: Kim, S, et al.
Julkaistu: (2011)